肺癌 - 流行病学,发病,治疗和分子方面 (文献评论)
Beata Smolarz1, Honorata Łukasiewicz2, Dariusz Samulak3,4
1Laboratory of Cancer Genetics, Department of Pathology, Polish Mother's Memorial Hospital Research Institute, 93-338 Lodz, Poland.
International journal of molecular sciences
|March 13, 2025
概括
长期吸烟仍然是肺癌的主要危险因素. 最近分子向疗法的进展为特定的肺癌亚型提供了改进的治疗选择,提高了患者的预后.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 流行病学 流行病学
背景情况:
- 肺癌是全球癌症死亡的主要原因之一.
- 尽管取得了进展,但患者的存活率仍然低于最佳水平.
- 长期吸烟是肺癌的主要危险因素.
研究的目的:
- 介绍有关肺癌流行病学,病变发生和治疗的最新数据.
- 突出最近的分子发现及其治疗含义.
- 讨论正在进行的关于肺癌新型分子点的研究.
主要方法:
- 对流行病学和实验研究的审查.
- 对肺癌分子变化的分析.
- 对针对特定突变的向疗法的评估.
主要成果:
- 针对EGFR突变和ALK/ROS1转位的氨酸激酶抑制剂已被批准用于晚期腺癌.
- 对状细胞癌的分子评估尚未成为标准.
- 目前正在进行的研究探索了ROS,MET,FGFR,DDR-2和RET等目标.
结论:
- 向疗法已在特定的肺癌亚型中显示出有效性.
- 对分子点的进一步研究对于改善治疗结果至关重要.
- 诊断和治疗方面的进步为肺癌患者更好的预后提供了希望.
更多相关视频
11:15Next Generation Sequencing for the Detection of Actionable Mutations in Solid and Liquid Tumors
Published on: September 20, 2016
24.3K
10:21Author Spotlight: Exploring the Role of Inflammation in the Co-occurrence of Primary Sjogren's Syndrome and Lung Adenocarcinoma
Published on: September 20, 2024
365
相关概念视频
Cancer Therapies
7.5K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.5K
Statistical Methods for Analyzing Epidemiological Data
275
Epidemiological data primarily involves information on specific populations' occurrence, distribution, and determinants of health and diseases. This data is crucial for understanding disease patterns and impacts, aiding public health decision-making and disease prevention strategies. The analysis of epidemiological data employs various statistical methods to interpret health-related data effectively. Here are some commonly used methods:
275
Targeted Cancer Therapies
7.4K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.4K
Cancer Survival Analysis
315
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
315
Adaptive Mechanisms in Cancer Cells
5.7K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.7K
Treatment Resistant Cancers
3.2K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.2K
